BRITISH AMERICAN TOBACCO PLC
15 October 1999
RESOUNDING SUPPORT FOR ACQUISITION OF IMASCO SHARES
At an Extraordinary General Meeting held this morning, shareholders of
British American Tobacco p.l.c. voted resoundingly in favour of the
resolution to approve the acquisition of the outstanding 58% of the
shares in Imasco Limited that are not already owned by the British
American Tobacco Group and the interconditional disposal of shares in
CT Financial Services to Toronto Dominion Bank.
Approval is required from Imasco's shareholders and a special meeting
for this purpose is expected to be held in January 2000. Conditional
upon this and other regulatory approvals, completion of the deal will
be in the first quarter 2000.
Martin Broughton said 'In supporting our proposals, I am pleased that
our shareholders have once again endorsed our strategy to become the
world's leading international tobacco company. I believe that the
transaction is the most efficient way to ensure that the full
realisable value of Imasco's businesses is passed through to its
shareholders'.
For further information, please contact:
British American Tobacco Michael Prideaux 0171 845 1000
Ralph Edmondson
Denise Hart
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.